BUSINESS French pharma giant Sanofi posts 7 pct sales growth in 2022


French pharma giant Sanofi posts 7 pct sales growth in 2022


22:59, February 03, 2023

(File photo: AFP)

PARIS, Feb. 3 (Xinhua) -- French pharmaceutical giant Sanofi announced on Friday that its full-year 2022 sales increased by 7 percent year-on-year to around 43 billion euros (47 billion U.S. dollars).

Sales were up 12.2 percent in the United States, 6.2 percent in China and 2.4 percent in Europe, the company said in a press release.

The increase in sales in China was mainly due to the inclusion of several Sanofi drugs in the National Reimbursement Drug List (NRDL).

The group's net profit rose by 8 percent to 6.7 billion euros last year.

In 2022, net sales of pharmaceuticals increased by 6.9 percent, mainly driven by the Specialty Care and General Medicines portfolios. Vaccine sales were up 6.3 percent thanks to the progressive recovery of travel and booster vaccines.

The group also saw its consumer healthcare sales increase by 8.6 percent in 2022.

Sanofi's COVID-19 vaccine, VidPrevtyn Beta, was approved by the European Commission as a booster for the prevention of COVID-19 in adults who have previously received an mRNA (messenger ribonucleic acid) or adenoviral COVID-19 vaccine. (1 euro = 1.09 U.S. dollar)

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue